designed the OR logic‐gated CAR‐T cells with CD19 and CD123 targets, whose effect was tested in the treatment of relapsed/refractory B‐cell acute lymphoblastic leukemia (B‐ALL). Here, CD19 is linked to B-cell acute lymphoblastic leukemia.